神经肽与皮肤病(3)

http://www.100md.com 2007年3月1日 《中国医药学刊》 2007年第3期

     [7] Eedy DJ.Neuropeptides in skin.Br J Dermatol，1993,128:597-605.

    [8] Kahler CM ,Sitte BA,Reinisch N,et al.Stimulation of the chemotatic migration of human fibroblasts by substance.P.Eur J PhARMACOL,1993,249(3):281-6.

    [9] Parenti A,Amerini S,LeddsF,et al.The tachkininNK1receptor mediates the migration promoting effect of aubstance P on human skin fibroblasts in culture. Naunyn Schmiedebergs Arch Pharmacol,1996,353(3):475-81.

    [10] Pincelli C,et al.Neuropeptides in skin from patients with atopic dermatitis:an immunohistochemical study.Br J Dermaol,1990,122:745.

    [11] ALAbadie MSK .et al.The immnnoreativity of neuropeptides and general neuronal marker PGP9.5 in atopic dermatitis.Br J Dermaol,1992:127:430.

    [12] Anand P,et al.Neuropeptides in skin disease:incressed VIP in eczema and psoriasis but not axillary hyperhydrosis. Br J Dermatol ,1991,124:547.

    [13] 刘伟，赵庆利.菜瑞康.神经肽在变应性皮炎及正常皮肤中的分布观察.空军总医院学报, 1994，10(1)：7-9.

    [14] Ganneii A, Grotomoni G.Skin reactivity to neuropeptides in atopic dermatitis.Br J Dermatol,1989,121(6);681-688.

    [15] Wallengren J,Substance P antagonist inhibits immediate and delayed type cutaneous hypersensitivity reaction.Br J Dermatol,1991,124:324.

    [16] Ohshiroh,Suzuki K,Furuno T,et al.Atomic force microscopy to study direct neurte-mast cell (RBL) communication in vitro.Immunol Letters,2001,74:211-214.

    [17] 齐宝全，陆洁，段昕所，等.银屑病 皮损处角质形成细胞中P物质的研究[J].临床皮肤科杂志,2004,33(7):415-416.

    [18] Eedy DJ,Johnson CF,Shaw C,et al.Neuropeptides in psoriasis:an immunocytochemical and radioimmunoassay study.J Invest Dermatol ,1991,96:434-438.

    [19] Al,Abadie MSK,Senior HJ,Bleehen SS,et al.Neurogenic changes in psoriasis.An immunohistochemical study.J Invest Dermatol,1992,98:535.

    [20] Pincelli C,Fantini F,Romualdi P is diminished and vasoactive intestinal peptide is augmented in psoriatic lesions and these peptides exertdisparate effects on the proliferation of cultured human keratinocytes.J Invest Dermatol,1992,98:421-427.

    [21] Al,Abadie MSK et al.Neurppeptide and neuronal marker studies in vitiligo Br J Dermatol,1994,131:160.

    [22] 邓宝珍，邓宝丽.神经肽P物质在白殿风发病机制中的初探 中国皮肤性病学杂志,1997,11:145-146.

    [23] 曾维惠,谭升顺,姚聪君,等.白癜风皮损中NPY、VIP 和SP的研究.中国皮肤性病学杂志,2002,16(1):12-13.

    [24] Coebeler M et al.Arch Dermatol Res,1994;286:341.

    [25] Crowe H,Parkhouse N,McGrouther D,et al.Neuropeptide-containing nerves in painful hypertrophic human scar tissue[J].Br J Dermatol,1994,130(4):444-452.

    [26] 从 林，李世荣，许友奇.增生性瘢痕P物质含量的放免测定[J].中华整形烧伤外科杂志，1998，14(6)：401-403.

    [27] 冯小剑.神经肽与皮肤病.北京军区医药，1999，11(6)：446-447.

    [28] Eedy DJ,Johnston CF,Shaw C et al.Neuropeptions in psoriasis.J Invest Dermatol,1991,96:434.

    [29] Leslie TA et al.Br J DERMATOL,1994,131:423.

    [30] Bran SD,Tippins JR,Morris HR et al.Potent vasodilator activity of calcitonin gene-related peptide in human skin .J Invest Dermatol,1986,87(4):533-536.

    [31] Gustafsson H, Nilsson H. Endothlium-independent potentiation by Neuropeptide y of vasoconstrictor response in isolated arteries form rat and rabbit.Acta Physiol Scand,1990,138:503.(周建华　高顺强　林元珠)

上一页 第 1 2 3 4 页 下一页

    百拇医药网 http://www.100md.com/html/paper/1814-8824/2007/03/10-2.htm